Novavax Reports Second-Quarter 2014 Financial Results

Go back to Novavax Reports Second-Quarter 2014 Financial Results

Novavax, Inc. (NVAX) Posts Q2 Loss of 8c/Share

August 6, 2014 4:20 PM EDT

Novavax, Inc. (NASDAQ: NVAX) reported Q2 EPS of ($0.08), $0.01 worse than the analyst estimate of ($0.07). Revenue for the quarter came in at $8.26 million versus the consensus estimate of $8.74 million.

"Progress in the second quarter maintained the momentum built in both the first... More